Schedule 13D ownership disclosure

ACUTUS MED INC

Common Stock, par value $0.001 per share · CUSIP: 005111109

Event date: 2025-01-21

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deerfield Mgmt III, L.P.Reported CIK 0001610540

    Shares: 5,731,096 · Class: 5.54%

  • Deerfield Private Design Fund III, L.P.Reported CIK 0001603333

    Shares: 5,731,096 · Class: 5.54%

  • Deerfield Mgmt, L.P.Reported CIK 0001010823

    Shares: 3,895,263 · Class: 4.9%

  • Deerfield Partners, L.P.Reported CIK 0001301041

    Shares: 3,895,263 · Class: 4.9%

  • Deerfield Management Company, L.P.Reported CIK 0001009258

    Shares: 9,705,857 · Class: 9.1%

  • James E. FlynnReported CIK 0001352546

    Shares: 9,705,857 · Class: 9.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-008500
Form type
SCHEDULE 13D/A
Filer
Acutus Medical, Inc.
CIK
CIK 1522860
Filed
Jan 23, 2025
Reporting period
Jan 21, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub